» Articles » PMID: 36596155

Inulin Reduces Liver Triacylglycerol by Increasing Lipid Droplet Lipolysis in Fat-loaded Mice

Overview
Journal Food Res Int
Date 2023 Jan 3
PMID 36596155
Authors
Affiliations
Soon will be listed here.
Abstract

Increased consumption of high-fat low-fiber foods has been shown to contribute to the development of metabolic syndromes, such as fatty liver, obesity, diabetes, et al. Fermentable dietary fiber, such as inulin, is broadly used to mitigate host metabolic abnormalities. In this work, we studied systematically the effect of inulin on mice with metabolic disorders, induced by either short- or long-term high-fat feeding. As expected, inulin reduced the body weight of mice in both groups. However, it was found that inulin feeding could only increase energy expenditure, alleviate adiposity, and improve glucose intolerance in mice fed with high-fat diet (HFD) for 1 month but not for 4 months. Surprisingly, inulin supplementation could alleviate HFD-induced hepatic steatosis, mediated through increasing adipose triglyceride lipase (ATGL) on liver lipid droplets, in both groups. Gut microbiota in the short- and long-term fat-loaded mice were shown to be modulated differently, which may mediate the differential effects of inulin. These results may help in understanding the role and mechanism of fermentable fiber regulating host metabolism.

Citing Articles

Inulin alleviates atherosclerosis through improving lipid metabolism, inflammation, and gut microbiota in ApoE-knockout mice: the short-chain is more efficacious.

Zhang K, Zeng Y, Li J, Huang Y, Zhang N, Gong Y Front Pharmacol. 2024; 15:1445528.

PMID: 39449970 PMC: 11499155. DOI: 10.3389/fphar.2024.1445528.


Immunomodulatory effects of inulin and its intestinal metabolites.

Sheng W, Ji G, Zhang L Front Immunol. 2023; 14:1224092.

PMID: 37638034 PMC: 10449545. DOI: 10.3389/fimmu.2023.1224092.


Inulin ameliorates metabolic syndrome in high-fat diet-fed mice by regulating gut microbiota and bile acid excretion.

Huang S, Dong S, Lin L, Ma Q, Xu M, Ni L Front Pharmacol. 2023; 14:1226448.

PMID: 37554983 PMC: 10404850. DOI: 10.3389/fphar.2023.1226448.


Preparation, Structural Characterisation, and Bioactivities of Fructans: A Review.

Wang M, Cheong K Molecules. 2023; 28(4).

PMID: 36838601 PMC: 9967297. DOI: 10.3390/molecules28041613.